VeriMomkaempferol est-il sûr pendant la grossesse ?
No harmonised CLP (H360/H361) or CIR/SCCS cosmetic safety opinion was found for kaempferol, but multiple peer‑reviewed animal and in vitro studies show reproductive‑endocrine activity (e.g., progestogenic effects in ovariectomized rats and modulation of embryonic development in vitro), supporting a ‘suspected’ reproductive concern; systemic exposure from topical cosmetic use is likely low but measurable. (See rat in vivo progestogenic study and embryo/bovine in vitro studies; ECHA registration shows dossiers but not harmonised classification).
Alternatives sûres à kaempferol pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- kaempferol est-il sûr pendant la grossesse ?
- No harmonised CLP (H360/H361) or CIR/SCCS cosmetic safety opinion was found for kaempferol, but multiple peer‑reviewed animal and in vitro studies show reproductive‑endocrine activity (e.g., progestogenic effects in ovariectomized rats and modulation of embryonic development in vitro), supporting a ‘suspected’ reproductive concern; systemic exposure from topical cosmetic use is likely low but measurable. (See rat in vivo progestogenic study and embryo/bovine in vitro studies; ECHA registration shows dossiers but not harmonised classification).
- kaempferol est-il sûr pendant l'allaitement ?
- No specific human lactation data were found. Animal and mechanistic data showing endocrine activity and systemic bioactivity (progestogenic/estrogenic modulation) justify a suspected concern for breastfeeding (possible maternal systemic effects and theoretical transfer), while dermal cosmetic exposure is expected to give low but measurable systemic absorption. (See cited in vivo and mechanistic studies and ECHA registration).
- kaempferol est-il sûr pour la peau de bébé ?
- Infant‑specific reproductive evidence was not found (so hazard and mechanism are not increased beyond the adult assessment), but because kaempferol has measurable systemic bioactivity and is dermally absorbable, exposure for babies (0–3 yr) is higher due to immature barrier — exposure score increased by +1. No infant-specific toxicity studies were located. (See animal/mechanistic studies and absorption data).
- Comment VeriMom évalue-t-il kaempferol ?
- VeriMom évalue kaempferol à 40/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à kaempferol pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à kaempferol basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.